Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Year: 2020
Type: erratum
Abstract: Rammensee H, Wiesmüller K, Chandran PA, et al . A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. J Immuno Ther Cancer 2019;7:307. doi: 10.1186/s40425-019-0796-5. In the article titled ‘A new synthetic toll-like receptor 1/2
Institutions: Rutgers Cancer Institute, National Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W4229565800
